Having regard to recent M & A data from the US I think the US business will attract a EBITDA multiple of at least 15x.
The US business is positioning itself nicely at the front of the ESG wave. Add to that US infrastructure spending and a low interest rate driven M & A boom and you can see that the terms of any sale of the US business should be highly favourable.
If we assume EBITDA for the US business of A$45m for FY22 (FY21 A$37.2m) then the US business alone is worth $1.74 per share.
If you value the Asia Pac business on a conservative EBITDA x 8 then it is worth around 18.5c on forward earnings of A$9m for FY22 (FY21 A$8m).
The independent expert valued Intega on an EBITDA multiple of around 8 for the purpose of the demerger. That was before the M & A boom ramped up.
Then you have ID which is harder to value but is certainly worth something. Let's say its worth 4c per share on EBITDA of A$2m x 8.
I think @CaptainBarnacles $2 plus on a sum of the parts basis is realistic.
Just my opinion. DYOR.
Cheers
- Forums
- ASX - By Stock
- CDD
- Ann: Cardno Announces FY21 Results
Ann: Cardno Announces FY21 Results, page-7
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CDD (ASX) to my watchlist
|
|||||
Last
37.5¢ |
Change
-0.020(5.06%) |
Mkt cap ! $14.64M |
Open | High | Low | Value | Volume |
39.5¢ | 39.5¢ | 37.0¢ | $6.423K | 16.99K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3208 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 7000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3208 | 0.350 |
2 | 6010 | 0.345 |
3 | 64500 | 0.340 |
1 | 20000 | 0.335 |
4 | 26137 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 7000 | 1 |
0.395 | 14781 | 3 |
0.410 | 20000 | 1 |
0.415 | 49940 | 2 |
0.420 | 4382 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
CDD (ASX) Chart |